BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29983692)

  • 1. Expanding the Spectrum of Dopa-Responsive Dystonia (DRD) and Proposal for New Definition: DRD, DRD-plus, and DRD Look-alike.
    Lee WW; Jeon B; Kim R
    J Korean Med Sci; 2018 Jul; 33(28):e184. PubMed ID: 29983692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopa-responsive dystonia, DRD-plus and DRD look-alike: a pragmatic review.
    Cherian A; Paramasivan NK; Divya KP
    Acta Neurol Belg; 2021 Jun; 121(3):613-623. PubMed ID: 33453040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency.
    Jeon BS
    J Korean Med Sci; 1997 Aug; 12(4):269-79. PubMed ID: 9288624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
    Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
    Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of dopa-responsive dystonia and related disorders.
    Lee WW; Jeon BS
    Curr Neurol Neurosci Rep; 2014 Jul; 14(7):461. PubMed ID: 24844652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to levodopa treatment in dopa-responsive dystonia.
    Nutt JG; Nygaard TG
    Arch Neurol; 2001 Jun; 58(6):905-10. PubMed ID: 11405805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial sonography in dopa-responsive dystonia.
    Svetel M; Tomić A; Mijajlović M; Dobričić V; Novaković I; Pekmezović T; Brajković L; Kostić VS
    Eur J Neurol; 2017 Jan; 24(1):161-166. PubMed ID: 27731537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of Treatment Outcome in Patients with Dopa-responsive Dystonia (DRD) and DRD-Plus.
    Kim R; Jeon B; Lee WW
    Mov Disord Clin Pract; 2016; 3(5):435-442. PubMed ID: 30363598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies].
    Furukawa Y
    Rinsho Shinkeigaku; 2006 Jan; 46(1):19-34. PubMed ID: 16541791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new knock-in mouse model of l-DOPA-responsive dystonia.
    Rose SJ; Yu XY; Heinzer AK; Harrast P; Fan X; Raike RS; Thompson VB; Pare JF; Weinshenker D; Smith Y; Jinnah HA; Hess EJ
    Brain; 2015 Oct; 138(Pt 10):2987-3002. PubMed ID: 26220941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopa-responsive dystonia--clinical and genetic heterogeneity.
    Wijemanne S; Jankovic J
    Nat Rev Neurol; 2015 Jul; 11(7):414-24. PubMed ID: 26100751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of dopa-responsive dystonia.
    Ichinose H; Suzuki T; Inagaki H; Ohye T; Nagatsu T
    Biol Chem; 1999 Dec; 380(12):1355-64. PubMed ID: 10661862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice.
    Rose SJ; Harrast P; Donsante C; Fan X; Joers V; Tansey MG; Jinnah HA; Hess EJ
    Mov Disord; 2017 Dec; 32(12):1694-1700. PubMed ID: 28949038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of presynaptic nigrostriatal dopaminergic function and clinical heterogeneity in a dopa-responsive dystonia family with GCH-1 gene mutation.
    Lin JJ; Lu CS; Tsai CH
    J Neurol; 2018 Mar; 265(3):478-485. PubMed ID: 29290055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
    De La Fuente-Fernández R; Furtado S; Guttman M; Furukawa Y; Lee CS; Calne DB; Ruth TJ; Stoessl AJ
    Synapse; 2003 Jul; 49(1):20-8. PubMed ID: 12710012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia.
    Sato K; Sumi-Ichinose C; Kaji R; Ikemoto K; Nomura T; Nagatsu I; Ichinose H; Ito M; Sako W; Nagahiro S; Graybiel AM; Goto S
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12551-6. PubMed ID: 18713855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GCH1 mutations in dopa-responsive dystonia and Parkinson's disease.
    Yoshino H; Nishioka K; Li Y; Oji Y; Oyama G; Hatano T; Machida Y; Shimo Y; Hayashida A; Ikeda A; Mogushi K; Shibagaki Y; Hosaka A; Iwanaga H; Fujitake J; Ohi T; Miyazaki D; Sekijima Y; Oki M; Kusaka H; Fujimoto KI; Ugawa Y; Funayama M; Hattori N
    J Neurol; 2018 Aug; 265(8):1860-1870. PubMed ID: 29948246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors.
    Rinne JO; Iivanainen M; Metsähonkala L; Vainionpää L; Pääkkönen L; Någren K; Helenius H
    J Neural Transm (Vienna); 2004 Jan; 111(1):59-67. PubMed ID: 14714216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal dopamine transporter binding in dopa responsive dystonia.
    Huang CC; Yen TC; Weng YH; Lu CS
    J Neurol; 2002 Aug; 249(8):1016-20. PubMed ID: 12195447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.